Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Javier Fernández‐Ruíz, Ismael Galve‐Roperh, Onintza Sagredo, et al.
European Neuropsychopharmacology (2020) Vol. 36, pp. 217-234
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Cannabinoids: Therapeutic Use in Clinical Practice
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3344-3344
Open Access | Times Cited: 146
Cannabis for Chronic Pain: Mechanistic Insights and Therapeutic Challenges
Carla Matos, Ana Teresa Pereira, Maria João Dias, et al.
Stresses (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies
Deepak Mishra, Radha Raman Maurya, K. Ravi Kumar, et al.
Journal of Molecular Liquids (2021) Vol. 335, pp. 116185-116185
Open Access | Times Cited: 47
Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
Joseph Palumbo, Brian F. Thomas, Dejan B. Budimirovic, et al.
Journal of Neurodevelopmental Disorders (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Supercritical fluid extraction of cannabinoids and their analysis by liquid chromatography and supercritical fluid chromatography: A short review
Matjaž Rantaša, Gal Slaček, Željko Knez, et al.
Journal of CO2 Utilization (2024) Vol. 86, pp. 102907-102907
Open Access | Times Cited: 6
Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy
Vincenzo Pota, Pasquale Sansone, Sara De Sarno, et al.
Behavioural Neurology (2024) Vol. 2024, pp. 1-23
Open Access | Times Cited: 5
The Effects of Cannabinoids on Sleep
Bhanu Prakash Kolla, Lisa Hayes, Chaun Cox, et al.
Journal of Primary Care & Community Health (2022) Vol. 13
Open Access | Times Cited: 18
Cannabinoids, Endocannabinoids, and Synthetic Cannabimimetic Molecules in Neuromuscular Disorders
Fabio Arturo Iannotti
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 238-238
Open Access | Times Cited: 8
Plant Soft Rot Development and Regulation from the Viewpoint of Transcriptomic Profiling
Ivan Tsers, Vladimir Gorshkov, Natalia Gogoleva, et al.
Plants (2020) Vol. 9, Iss. 9, pp. 1176-1176
Open Access | Times Cited: 21
Antidepressant-like effects of cannabidiol in a rat model of early-life stress with or without adolescent cocaine exposure
Cristian Bis‐Humbert, Rubén García‐Cabrerizo, M. Julia García‐Fuster
Pharmacological Reports (2021) Vol. 73, Iss. 4, pp. 1195-1202
Closed Access | Times Cited: 14
Increased 2-arachidonoyl-sn-glycerol levels normalize cortical responses to sound and improve behaviors in Fmr1 KO mice
Patricia S. Pirbhoy, Carrie R. Jonak, Rashid Syed, et al.
Journal of Neurodevelopmental Disorders (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB1 receptors
Juan Paraíso‐Luna, José Aguareles, Ricardo Martín, et al.
Development (2020) Vol. 147, Iss. 24
Open Access | Times Cited: 13
Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101
Todd M. Stollenwerk, Samantha Pollock, Cecilia J. Hillard
Molecules (2021) Vol. 26, Iss. 17, pp. 5354-5354
Open Access | Times Cited: 11
Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1
Leyre Echeazarra, Gontzal Garcı́a del Caño, Sergio Barrondo, et al.
Histochemistry and Cell Biology (2021) Vol. 156, Iss. 5, pp. 479-502
Open Access | Times Cited: 10
Trends in Web Searches About the Causes and Treatments of Autism Over the Past 15 Years: Exploratory Infodemiology Study
Florencia Saposnik, Joelene Huber
JMIR Pediatrics and Parenting (2020) Vol. 3, Iss. 2, pp. e20913-e20913
Open Access | Times Cited: 9
New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence
Rocío Saravia, Marc Ten-Blanco, Inmaculada Pereda-Pérez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13316-13316
Open Access | Times Cited: 9
The endocannabinoid system as a therapeutic target for schizophrenia: Failures and potentials
Alexandre Seillier
Neuroscience Letters (2021) Vol. 759, pp. 136064-136064
Closed Access | Times Cited: 8
Cannabis research: Risks of recreational use and potential medical applications
Rafaël Maldonado, Marta Torrens
European Neuropsychopharmacology (2020) Vol. 36, pp. 167-168
Open Access | Times Cited: 6
Predictors of perceived symptom change with acute cannabis use for mental health conditions in a naturalistic sample: A machine learning approach
Nirushi Kuhathasan, Pedro L. Ballester, Luciano Minuzzi, et al.
Comprehensive Psychiatry (2023) Vol. 122, pp. 152377-152377
Open Access | Times Cited: 2
Using Population Pharmacokinetic Modeling to Estimate Exposure to Δ9-Tetrahydrocannabinol in an Observational Study of Cannabis Smokers in Colorado
Cristina Sempio, L. Cinnamon Bidwell, Kent E. Hutchison, et al.
Therapeutic Drug Monitoring (2021) Vol. 43, Iss. 4, pp. 536-545
Open Access | Times Cited: 4
Cannabidiol use among patients with substance use disorders
Patrik Roser, Benedikt Habermeyer, Norbert Scherbaum, et al.
Journal of Substance Use (2022) Vol. 28, Iss. 6, pp. 982-988
Closed Access | Times Cited: 3
Medical use of cannabis and psychedelics in treating symptoms of mental disorders among military and veteran populations: A systematic review
Houyu Zhao, Kun Liang, Yiqun Fang
Theoretical and Natural Science (2024) Vol. 32, Iss. 1, pp. 298-312
Closed Access
Therapeutic application of cannabis and its derivatives
Moitreyee Chattopadhyay, Ananya Chanda, Arghya Bhattacharya
Elsevier eBooks (2024), pp. 93-125
Closed Access
Phyto, Synthetic, and Endogenous Cannabinoids as Theoretical Possibilities of Therapeutic Molecules for the Treatment of Addictions
Virna Margarita Martín Giménez, Walter Manucha
(2024), pp. 205-209
Closed Access
Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool
Abram J. Lyons, Gordon Kordas, Elizabeth T. Smith, et al.
Journal of Psychoactive Drugs (2023) Vol. 55, Iss. 5, pp. 592-600
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top